Age-related Differences in Recall of Information and Handling of Chemotherapy-related Side Effects in Cancer Patients: The ReCap Study.
age
chemotherapy
information
recall
side effects
Journal
The oncologist
ISSN: 1549-490X
Titre abrégé: Oncologist
Pays: England
ID NLM: 9607837
Informations de publication
Date de publication:
04 03 2022
04 03 2022
Historique:
received:
28
06
2021
accepted:
23
09
2021
entrez:
31
5
2022
pubmed:
1
6
2022
medline:
3
6
2022
Statut:
ppublish
Résumé
To prevent severe toxicity and hospital admissions, adequate management and recall of information about side effects are crucial and health literacy plays an important role. If age-related factors impact recall of given information and handling of side effects, revised ways to give information are required. We undertook a questionnaire-based survey among 188 newly diagnosed patients with pancreatic cancer or colorectal cancer and chemo-naive patients with prostate cancer treated with adjuvant or first-line palliative chemotherapy comprising satisfaction with given information, recall of potential side effects, and handling of hypothetical side effect scenarios. We evaluated the association between baseline characteristics, ie, age, frailty (G8 score), comorbidity (Charlson Comorbidity Index), cognitive function (Mini-Cog), satisfaction, recall of information, and handling of side effects. Reduced ability to recall information about several side effects (eg, chest pain) was associated with older age (odds ratio adjusted for cancer [aOR] 0.94 [95% CI, 0.88-0.98]) and poor cognitive screening (aOR 0.56 [95% CI, 0.33-0.91]). Insufficient or dangerous handling of side effects was associated with older age (aOR 0.96 (95% CI, 0.92-0.99)) and cognitive impairment (aOR 0.70 [95% CI, 0.50-0.95]). Older age and poor cognitive screening may impact patients' ability to understand and adequately handle chemotherapy-related side effects. Cognitive screening and focus on individual ways to give information including assessment of recall and handling are needed.
Sections du résumé
BACKGROUND
To prevent severe toxicity and hospital admissions, adequate management and recall of information about side effects are crucial and health literacy plays an important role. If age-related factors impact recall of given information and handling of side effects, revised ways to give information are required.
PATIENTS AND METHODS
We undertook a questionnaire-based survey among 188 newly diagnosed patients with pancreatic cancer or colorectal cancer and chemo-naive patients with prostate cancer treated with adjuvant or first-line palliative chemotherapy comprising satisfaction with given information, recall of potential side effects, and handling of hypothetical side effect scenarios. We evaluated the association between baseline characteristics, ie, age, frailty (G8 score), comorbidity (Charlson Comorbidity Index), cognitive function (Mini-Cog), satisfaction, recall of information, and handling of side effects.
RESULTS
Reduced ability to recall information about several side effects (eg, chest pain) was associated with older age (odds ratio adjusted for cancer [aOR] 0.94 [95% CI, 0.88-0.98]) and poor cognitive screening (aOR 0.56 [95% CI, 0.33-0.91]). Insufficient or dangerous handling of side effects was associated with older age (aOR 0.96 (95% CI, 0.92-0.99)) and cognitive impairment (aOR 0.70 [95% CI, 0.50-0.95]).
CONCLUSION
Older age and poor cognitive screening may impact patients' ability to understand and adequately handle chemotherapy-related side effects. Cognitive screening and focus on individual ways to give information including assessment of recall and handling are needed.
Identifiants
pubmed: 35641212
pii: 6525179
doi: 10.1093/oncolo/oyab034
pmc: PMC8895734
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e185-e193Informations de copyright
© The Author(s) 2022. Published by Oxford University Press.
Références
Acta Oncol. 2016 Jun;55(6):671-9
pubmed: 27031166
CA Cancer J Clin. 2014 Jul-Aug;64(4):252-71
pubmed: 24890451
Front Psychol. 2019 Nov 15;10:2584
pubmed: 31803117
BMC Cancer. 2017 Aug 16;17(1):548
pubmed: 28814275
Ann Oncol. 2015 Feb;26(2):288-300
pubmed: 24936581
J Clin Oncol. 2008 Nov 20;26(33):5450-7
pubmed: 18936478
Int J Geriatr Psychiatry. 2006 Apr;21(4):349-55
pubmed: 16534774
Oncol Lett. 2019 Jul;18(1):507-517
pubmed: 31289522
Cancer. 2018 Nov 1;124(21):4202-4210
pubmed: 30264856
Eur Urol Focus. 2017 Oct;3(4-5):330-339
pubmed: 29331624
Expert Opin Drug Saf. 2020 Sep;19(9):1059-1061
pubmed: 32744078
Patient Educ Couns. 2020 Mar;103(3):514-520
pubmed: 31585818
Eur J Cancer Care (Engl). 2014 Sep;23(5):585-93
pubmed: 24393204
Acta Oncol. 2019 Feb;58(2):182-188
pubmed: 30264632
Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
Eur J Cancer Care (Engl). 2017 Mar;26(2):
pubmed: 28004440
Syst Rev. 2019 May 10;8(1):112
pubmed: 31077247
Eur J Cancer. 2010 Oct;46(15):2726-38
pubmed: 20674333
Ann Oncol. 2012 Aug;23(8):2166-2172
pubmed: 22250183
J Psychosom Res. 2011 May;70(5):403-10
pubmed: 21511070
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Gerontologist. 2008 Apr;48(2):149-57
pubmed: 18483427
J Am Geriatr Soc. 2003 Oct;51(10):1451-4
pubmed: 14511167
Arch Gynecol Obstet. 2012 Dec;286(6):1487-505
pubmed: 23011733
Health (London). 2011 Mar;15(2):153-72
pubmed: 21177708
Eur J Oncol Nurs. 2010 Dec;14(5):400-9
pubmed: 20149733
Public Health Genomics. 2011;14(4-5):307-16
pubmed: 20829577
PLoS One. 2017 Oct 10;12(10):e0184360
pubmed: 29016607
J Clin Oncol. 2012 Jun 10;30(17):2036-8
pubmed: 22547597
J Clin Oncol. 2018 Aug 1;36(22):2326-2347
pubmed: 29782209
J Geriatr Oncol. 2013 Jul;4(3):227-34
pubmed: 23795224
Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):1996-2005
pubmed: 21980007
Cancer. 2008 Dec 15;113(12 Suppl):3530-9
pubmed: 19058147
JAMA Intern Med. 2015 Sep;175(9):1450-8
pubmed: 26052687
Gerontologist. 2017 Apr 1;57(2):261-268
pubmed: 26209450
Eur J Cancer Clin Oncol. 1983 Feb;19(2):203-8
pubmed: 6681766
Cancer J. 2017 Jul/Aug;23(4):206-210
pubmed: 28731942
J Clin Oncol. 2011 Sep 1;29(25):3457-65
pubmed: 21810685
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
Ann Oncol. 2006 Jan;17(1):5-19
pubmed: 16143594
J Clin Epidemiol. 1994 Nov;47(11):1245-51
pubmed: 7722560
Oncol Nurs Forum. 2016 Mar;43(2):169-78
pubmed: 26906128
Ann Oncol. 2013 Oct;24 Suppl 7:vii30-35
pubmed: 24001760
PLoS One. 2012;7(7):e39013
pubmed: 22848347
Support Care Cancer. 2012 Oct;20(10):2553-7
pubmed: 22270087